Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 189Lymphoid 98Other hematologic neoplasm 70Breast 13Myeloid 10Genitourinary 9Gastrointestinal 8CNS 8Dermatologic 7Tumor-Agnostic 6Thoracic 5Head & Neck 5Gynecologic 3Sarcoma 2Other 2Other solid neoplasm 1Other neoplasm 1

Conditions

Neoplasms 4Neoplasm Metastasis 1Carcinoma 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Calcium Dobesilate × Tumor-Agnostic × Clear all
NCT05977998 2026-05-22

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled
Tumor-Agnostic

Carcinoma

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting
472 enrolled
Tumor-Agnostic

Neoplasms

NCT03583255 2025-12-26

Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
99 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02815319 2020-04-28

REaCT-dex

Ottawa Hospital Research Institute

Phase 4 Completed
60 enrolled
Tumor-Agnostic

Neoplasms

NCT02257476 2017-02-07

Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors

Emory University

Phase 1 Completed
22 enrolled
Tumor-Agnostic

Neoplasms

NCT01640340 2013-11-07

Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)

Ohio State University Comprehensive Cancer Center

Phase NA Completed
40 enrolled 12 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡